HEADER TRANSFERASE/TRANSFERASE INHIBITOR 28-MAR-12 4EEV
TITLE CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH LY2801653
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 1038-1346);
COMPND 5 SYNONYM: HGF RECEPTOR, HGF/SF RECEPTOR, PROTO-ONCOGENE C-MET, SCATTER
COMPND 6 FACTOR RECEPTOR, SF RECEPTOR, TYROSINE-PROTEIN KINASE MET;
COMPND 7 EC: 2.7.10.1;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: MET;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS PROTEIN TYROSINE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR Y.WANG,S.L.STOUT
REVDAT 3 28-FEB-24 4EEV 1 REMARK SEQADV
REVDAT 2 04-SEP-13 4EEV 1 JRNL
REVDAT 1 10-APR-13 4EEV 0
JRNL AUTH S.B.YAN,V.L.PEEK,R.AJAMIE,S.G.BUCHANAN,J.R.GRAFF,
JRNL AUTH 2 S.A.HEIDLER,Y.H.HUI,K.L.HUSS,B.W.KONICEK,J.R.MANRO,C.SHIH,
JRNL AUTH 3 J.A.STEWART,T.R.STEWART,S.L.STOUT,M.T.UHLIK,S.L.UM,Y.WANG,
JRNL AUTH 4 W.WU,L.YAN,W.J.YANG,B.ZHONG,R.A.WALGREN
JRNL TITL LY2801653 IS AN ORALLY BIOAVAILABLE MULTI-KINASE INHIBITOR
JRNL TITL 2 WITH POTENT ACTIVITY AGAINST MET, MST1R, AND OTHER
JRNL TITL 3 ONCOPROTEINS, AND DISPLAYS ANTI-TUMOR ACTIVITIES IN MOUSE
JRNL TITL 4 XENOGRAFT MODELS.
JRNL REF INVEST NEW DRUGS V. 31 833 2013
JRNL REFN ISSN 0167-6997
JRNL PMID 23275061
JRNL DOI 10.1007/S10637-012-9912-9
REMARK 2
REMARK 2 RESOLUTION. 1.80 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.94
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7
REMARK 3 NUMBER OF REFLECTIONS : 27552
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.190
REMARK 3 R VALUE (WORKING SET) : 0.189
REMARK 3 FREE R VALUE : 0.215
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1388
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1924
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.85
REMARK 3 BIN R VALUE (WORKING SET) : 0.2340
REMARK 3 BIN FREE R VALUE SET COUNT : 97
REMARK 3 BIN FREE R VALUE : 0.2810
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2206
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 41
REMARK 3 SOLVENT ATOMS : 125
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 28.00
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.26
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 1.75000
REMARK 3 B22 (A**2) : 0.48000
REMARK 3 B33 (A**2) : -2.23000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.132
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.120
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.086
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.757
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2346 ; 0.014 ; 0.019
REMARK 3 BOND LENGTHS OTHERS (A): 1555 ; 0.006 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3198 ; 1.588 ; 1.986
REMARK 3 BOND ANGLES OTHERS (DEGREES): 3817 ; 0.973 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 293 ; 5.193 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 89 ;31.668 ;23.596
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 394 ;12.696 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;15.998 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 361 ; 0.099 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2644 ; 0.007 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): 463 ; 0.001 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : BABINET MODEL WITH MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY
REMARK 4
REMARK 4 4EEV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-APR-12.
REMARK 100 THE DEPOSITION ID IS D_1000071529.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : NULL
REMARK 200 TEMPERATURE (KELVIN) : NULL
REMARK 200 PH : 7.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 31-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : NULL
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200 DATA SCALING SOFTWARE : SCALA 2.7.2
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45914
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.511
REMARK 200 RESOLUTION RANGE LOW (A) : 19.940
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0
REMARK 200 DATA REDUNDANCY : 9.400
REMARK 200 R MERGE (I) : 0.08600
REMARK 200 R SYM (I) : 0.08600
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.1000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.51
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59
REMARK 200 COMPLETENESS FOR SHELL (%) : 94.2
REMARK 200 DATA REDUNDANCY IN SHELL : 8.50
REMARK 200 R MERGE FOR SHELL (I) : 0.06000
REMARK 200 R SYM FOR SHELL (I) : 6.01700
REMARK 200 <I/SIGMA(I)> FOR SHELL : 0.100
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 38.80
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG 10.000, 0.1 M HEPES, AND 5%
REMARK 280 ETHYLENE GLYCOL, PH 7.0, VAPOR DIFFUSION, HANGING DROP,
REMARK 280 TEMPERATURE 298.0K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.25400
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.81550
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.94300
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.81550
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.25400
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.94300
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 1030
REMARK 465 HIS A 1031
REMARK 465 HIS A 1032
REMARK 465 HIS A 1033
REMARK 465 HIS A 1034
REMARK 465 HIS A 1035
REMARK 465 HIS A 1036
REMARK 465 MET A 1037
REMARK 465 GLY A 1038
REMARK 465 ASP A 1039
REMARK 465 SER A 1040
REMARK 465 ASP A 1041
REMARK 465 ILE A 1042
REMARK 465 SER A 1043
REMARK 465 SER A 1044
REMARK 465 LEU A 1225
REMARK 465 ALA A 1226
REMARK 465 ARG A 1227
REMARK 465 ASP A 1228
REMARK 465 MET A 1229
REMARK 465 TYR A 1230
REMARK 465 ASP A 1231
REMARK 465 LYS A 1232
REMARK 465 GLU A 1233
REMARK 465 TYR A 1234
REMARK 465 TYR A 1235
REMARK 465 SER A 1236
REMARK 465 VAL A 1237
REMARK 465 HIS A 1238
REMARK 465 ASN A 1239
REMARK 465 LYS A 1240
REMARK 465 THR A 1241
REMARK 465 GLY A 1242
REMARK 465 ALA A 1243
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ASN A1049 CG OD1 ND2
REMARK 470 ARG A1086 CD NE CZ NH1 NH2
REMARK 470 PHE A1089 CG CD1 CD2 CE1 CE2 CZ
REMARK 470 ASP A1101 CG OD1 OD2
REMARK 470 ARG A1148 CD NE CZ NH1 NH2
REMARK 470 GLU A1150 CG CD OE1 OE2
REMARK 470 LYS A1244 CG CD CE NZ
REMARK 470 ASP A1286 CG OD1 OD2
REMARK 470 ASN A1288 CG OD1 ND2
REMARK 470 GLU A1314 CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASN A1113 -113.20 -77.63
REMARK 500 ASN A1175 72.31 22.38
REMARK 500 ARG A1203 -16.27 78.43
REMARK 500 ASP A1204 48.59 -146.43
REMARK 500 TYR A1307 -11.23 76.74
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L1X A 1401
DBREF 4EEV A 1038 1346 UNP P08581 MET_HUMAN 1038 1346
SEQADV 4EEV MET A 1030 UNP P08581 INITIATING METHIONINE
SEQADV 4EEV HIS A 1031 UNP P08581 EXPRESSION TAG
SEQADV 4EEV HIS A 1032 UNP P08581 EXPRESSION TAG
SEQADV 4EEV HIS A 1033 UNP P08581 EXPRESSION TAG
SEQADV 4EEV HIS A 1034 UNP P08581 EXPRESSION TAG
SEQADV 4EEV HIS A 1035 UNP P08581 EXPRESSION TAG
SEQADV 4EEV HIS A 1036 UNP P08581 EXPRESSION TAG
SEQADV 4EEV MET A 1037 UNP P08581 EXPRESSION TAG
SEQRES 1 A 317 MET HIS HIS HIS HIS HIS HIS MET GLY ASP SER ASP ILE
SEQRES 2 A 317 SER SER PRO LEU LEU GLN ASN THR VAL HIS ILE ASP LEU
SEQRES 3 A 317 SER ALA LEU ASN PRO GLU LEU VAL GLN ALA VAL GLN HIS
SEQRES 4 A 317 VAL VAL ILE GLY PRO SER SER LEU ILE VAL HIS PHE ASN
SEQRES 5 A 317 GLU VAL ILE GLY ARG GLY HIS PHE GLY CYS VAL TYR HIS
SEQRES 6 A 317 GLY THR LEU LEU ASP ASN ASP GLY LYS LYS ILE HIS CYS
SEQRES 7 A 317 ALA VAL LYS SER LEU ASN ARG ILE THR ASP ILE GLY GLU
SEQRES 8 A 317 VAL SER GLN PHE LEU THR GLU GLY ILE ILE MET LYS ASP
SEQRES 9 A 317 PHE SER HIS PRO ASN VAL LEU SER LEU LEU GLY ILE CYS
SEQRES 10 A 317 LEU ARG SER GLU GLY SER PRO LEU VAL VAL LEU PRO TYR
SEQRES 11 A 317 MET LYS HIS GLY ASP LEU ARG ASN PHE ILE ARG ASN GLU
SEQRES 12 A 317 THR HIS ASN PRO THR VAL LYS ASP LEU ILE GLY PHE GLY
SEQRES 13 A 317 LEU GLN VAL ALA LYS GLY MET LYS TYR LEU ALA SER LYS
SEQRES 14 A 317 LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN CYS MET
SEQRES 15 A 317 LEU ASP GLU LYS PHE THR VAL LYS VAL ALA ASP PHE GLY
SEQRES 16 A 317 LEU ALA ARG ASP MET TYR ASP LYS GLU TYR TYR SER VAL
SEQRES 17 A 317 HIS ASN LYS THR GLY ALA LYS LEU PRO VAL LYS TRP MET
SEQRES 18 A 317 ALA LEU GLU SER LEU GLN THR GLN LYS PHE THR THR LYS
SEQRES 19 A 317 SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP GLU LEU
SEQRES 20 A 317 MET THR ARG GLY ALA PRO PRO TYR PRO ASP VAL ASN THR
SEQRES 21 A 317 PHE ASP ILE THR VAL TYR LEU LEU GLN GLY ARG ARG LEU
SEQRES 22 A 317 LEU GLN PRO GLU TYR CYS PRO ASP PRO LEU TYR GLU VAL
SEQRES 23 A 317 MET LEU LYS CYS TRP HIS PRO LYS ALA GLU MET ARG PRO
SEQRES 24 A 317 SER PHE SER GLU LEU VAL SER ARG ILE SER ALA ILE PHE
SEQRES 25 A 317 SER THR PHE ILE GLY
HET L1X A1401 41
HETNAM L1X N-(3-FLUORO-4-{[1-METHYL-6-(1H-PYRAZOL-4-YL)-1H-
HETNAM 2 L1X INDAZOL-5-YL]OXY}PHENYL)-1-(4-FLUOROPHENYL)-6-METHYL-
HETNAM 3 L1X 2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE
FORMUL 2 L1X C30 H22 F2 N6 O3
FORMUL 3 HOH *125(H2 O)
HELIX 1 1 LEU A 1047 VAL A 1051 5 5
HELIX 2 2 ASP A 1054 LEU A 1058 5 5
HELIX 3 3 ASN A 1059 VAL A 1069 1 11
HELIX 4 4 GLY A 1072 SER A 1074 5 3
HELIX 5 5 ASP A 1117 ASP A 1133 1 17
HELIX 6 6 ASP A 1164 ASN A 1171 1 8
HELIX 7 7 THR A 1177 LYS A 1198 1 22
HELIX 8 8 ALA A 1206 ARG A 1208 5 3
HELIX 9 9 PRO A 1246 MET A 1250 5 5
HELIX 10 10 ALA A 1251 GLN A 1258 1 8
HELIX 11 11 THR A 1261 THR A 1278 1 18
HELIX 12 12 ASP A 1291 GLN A 1298 1 8
HELIX 13 13 PRO A 1309 TRP A 1320 1 12
HELIX 14 14 LYS A 1323 ARG A 1327 5 5
HELIX 15 15 SER A 1329 PHE A 1344 1 16
SHEET 1 A 5 LEU A1076 ARG A1086 0
SHEET 2 A 5 GLY A1090 LEU A1098 -1 O VAL A1092 N ILE A1084
SHEET 3 A 5 LYS A1104 LEU A1112 -1 O VAL A1109 N TYR A1093
SHEET 4 A 5 LEU A1154 PRO A1158 -1 O VAL A1155 N LYS A1110
SHEET 5 A 5 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156
SHEET 1 B 2 CYS A1210 LEU A1212 0
SHEET 2 B 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211
SITE 1 AC1 17 ILE A1084 VAL A1092 ALA A1108 LYS A1110
SITE 2 AC1 17 GLU A1127 ILE A1130 MET A1131 LEU A1157
SITE 3 AC1 17 PRO A1158 TYR A1159 MET A1160 LEU A1195
SITE 4 AC1 17 VAL A1220 ALA A1221 ASP A1222 PHE A1223
SITE 5 AC1 17 HOH A1618
CRYST1 40.508 63.886 111.631 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.024686 0.000000 0.000000 0.00000
SCALE2 0.000000 0.015653 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008958 0.00000